Literature DB >> 16416142

[Peyronie's disease. Conservative and surgical therapy].

E W Hauck1, T Diemer, W Weidner.   

Abstract

Peyronie's disease is characterized by the formation of a plaque of the tunica albuginea that leads to a mainly dorsally directed penile curvature and penile shortening due to scarification. The exact ethiopathology remains unclear. The natural history of the disease is variable, ranging from spontaneous remissions to chronic, and including severe penile curvature. Therapy should be conservative in the early, painful, progressive phase. No conservative medical or semi-invasive treatment modality, such as extracorporeal shock wave therapy or radiation therapy, is currently available for curing all of the symptoms of this disorder in all patients. All studies with a controlled design showed poor therapeutic outcomes that are frequently identical to the natural course. Surgical therapy should only be performed in the stable stage of the disease. This means that Peyronie's disease should have been present for at least 12 months, and the patient should not have suffered from pain or the progression of symptoms for at least 6 months. The surgical treatment modalities comprise plication procedures (Essed-Schroeder, Nesbit), plaque-incisions with grafting, and the insertion of penile implants with simultaneous correction of the curvature by "penile cracking" or incisions of the plaque.

Entities:  

Mesh:

Year:  2006        PMID: 16416142     DOI: 10.1007/s00120-005-0988-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

1.  Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease.

Authors:  F Montorsi; A Salonia; T Maga; L Bua; G Guazzoni; L Barbieri; G Barbagli; R Chiesa; G Pizzini; P Rigatti
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

2.  François de la Peyronie and the disease named after him.

Authors:  E W Hauck; W Weidner
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

Review 3.  Peyronie's disease: a review.

Authors:  Shahram S Gholami; Nestor F Gonzalez-Cadavid; Ching-Shwu Lin; Jacob Rajfer; Tom F Lue
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  The natural history of Peyronie's disease.

Authors:  M K Gelbard; F Dorey; K James
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

5.  Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.

Authors:  Ekkehard W Hauck; Ulrich O Mueller; Thomas Bschleipfer; Hans U Schmelz; Thorten Diemer; Wolfgang Weidner
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

6.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

7.  Venous patch graft for Peyronie's disease. Part I: technique.

Authors:  T F Lue; A I El-Sakka
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

8.  Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study.

Authors:  Wolfgang Weidner; Ekkehard W Hauck; Jörg Schnitker
Journal:  Eur Urol       Date:  2005-01-13       Impact factor: 20.096

9.  Long-term results of plaque thinning with carbide burs, small incisions and venous grafting for correcting complex penile curvature in Peyronie's disease: poor results of an "ideal" approach.

Authors:  Ekkehard W Hauck; Thomas Bschleipfer; Thorsten Diemer; Martina Manning; Immo Schroeder-Printzen; Wolfgana Weidner
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

10.  Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis.

Authors:  S K Wilson; M A Cleves; J R Delk
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

View more
  1 in total

1.  A self-reported long-term follow-up of patients operated with either shortening techniques or a TachoSil grafting procedure.

Authors:  Marcus Horstmann; Matthias Kwol; Bastian Amend; Joerg Hennenlotter; Arnulf Stenzl
Journal:  Asian J Androl       Date:  2011-01-17       Impact factor: 3.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.